Universal Biosensors Pty Ltd - Voluntary Administration

Universal Biosensors Pty Ltd, the Australian operating arm of Universal Biosensors, Inc. (ASX:UBI), has entered voluntary administration with KPMG’s David Hardy, James Dampney and Emily Seeckts appointed on 20 August 2025.

The Melbourne-based medtech group, known for its blood coagulation and wine analysis devices, faced recurring losses and cash shortfalls after efforts to secure a loan facility and fresh funding failed.

Administrators are continuing operations while canvassing interest from investors, with creditors to decide the company’s future in late September.